Cite
HARVARD Citation
Clausznitzer, D. et al. (2018). Quantitative Systems Pharmacology Model for Alzheimer Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option. CPT: pharmacometrics & systems pharmacology. pp. 759-770. [Online].